Kwee-Lan TanRegional Regulatory Lead, Emerging Markets at Boehringer IngelheimSpeaker
Profile
Kwee Lan Tan is the Head of the Regional Regulatory Lead Emerging Markets team at Boehringer Ingelheim International GmbH. In this role, she leads a team of Regional Regulatory Leads responsible for the therapeutic areas of inflammation and oncology. Over the past three years, she has actively engaged with various regulatory authorities, successfully driving the registration of new drug applications with Orphan drug designation.
Before her international role in Germany, Kwee Lan held the position of Head of Regulatory Affairs for Malaysia and Singapore in 2017. During her tenure, she established strong collaborations with local industry associations and health authorities, which included organizing workshops on disease education and shaping local regulations and policies.
In addition to her regulatory experience, Kwee Lan began her career in pharmacovigilance activities at Pfizer and Boehringer Ingelheim. Kwee Lan holds a Degree in Biotechnology and has 13 years of experience in the pharmaceutical industry.
Agenda Sessions
Transforming Challenges into Opportunities: Enhancing Patient Access in the Orphan Drug Landscape
, 11:20View Session